[Federal Register Volume 76, Number 81 (Wednesday, April 27, 2011)]
[Notices]
[Pages 23634-23636]
[FR Doc No: 2011-10099]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-64319; File No. SR-CHX-2011-04]

Self-Regulatory Organizations; Chicago Stock Exchange, Inc.;
Notice of Filing and Immediate Effectiveness of Proposed Rule Change To
Add the CHX Only Order Type

April 21, 2011.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'') \1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on April 19, 2011, the Chicago Stock Exchange, Inc. (``CHX'' or
``Exchange'') filed with the Securities and Exchange Commission
(``Commission'') the proposed rule change as described in Items I and
II below, which Items have been prepared by the Exchange. The
Commission is publishing this notice to solicit comments on the
proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    CHX proposes to amend CHX Article 1, Rule 2 (Order Types and
Conditions) and Article 20, Rules 4 (Eligible Orders) and 8 (Operation
of the Matching System) to add the CHX Only order type. The text of
this proposed rule change is available on the Exchange's Web site at
(http://www.chx.com) and in the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the CHX included statements
concerning the purpose of and basis for the proposed rule changes [sic]
and discussed any comments it received regarding the proposal. The text
of these statements may be examined at the places specified in Item IV
below. The CHX has prepared summaries, set forth in sections A, B and C
below, of the most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange proposes to amend CHX Article 1, Rule 2 (Order Types
and Conditions) and Article 20, Rules 4 (Eligible Orders) and 8
(Operation of the Matching System) to add the CHX Only order type. CHX
Only orders are designed to encourage displayed liquidity on the
Exchange and reduce automatic cancellations by the Exchange's core
trading facility, the Matching System, for orders which lock or cross
the best displayed quotes in the National Market System. CHX Only
orders will be automatically repriced by the Exchange, if necessary as
discussed below, to reside in the Matching System and be displayed to
the national market system at prices which are in conformity with
Regulation NMS and the short sale price test restrictions of Rule 201
of Regulation SHO. An order sender can enter instructions to have all
limit orders default to ``CHX Only'' and therefore be subject to the
repricing process. In addition, an order sender can enter instructions
to only use the repricing process if the CHX Only order locks the NBBO
at the time of order entry, and not if it crosses the NBBO. Such
instructions can be submitted on either an order-by-order or global
basis by the order sending firm. If such instructions are given and the
order crosses the NBBO, it will be rejected from the Matching System.
    As a general matter, CHX Only orders are limit orders which are
ranked and executed on the Exchange according to the provisions of Rule
8 of Article 20. By their nature, CHX Only orders are not eligible for
routing away by the Exchange to another trading center.\3\
---------------------------------------------------------------------------

    \3\ The CHX Only order type is therefore similar to the ``Do Not
Route'' order defined in Article 20, Rule 4.b(10), which also cannot
be routed to another destination. The repricing process defined in
this filing does not apply, however, to Do Not Route orders.
---------------------------------------------------------------------------

    In addition to the foregoing, a CHX Only order which, at the time
of entry to the Matching System, would cross a Protected Quotation, as
defined in Regulation NMS Rule 600(b)(58), will be automatically
repriced by the Exchange to the locking price and ranked at such price
in the Matching System. A CHX Only order that, if at the time of entry,
would create a violation of Rule 610(d) of Regulation NMS by locking or
crossing a Protected Quotation will be displayed by the Matching System
at one minimum price variation below the current NBO (for bids) or to
one minimum price variation above the current NBB (for offers) (the
``NMS repricing process'').\4\ In the event that

the NBBO changes such that the CHX Only order at the original locking
price would not lock or cross a Protected Quotation, the order subject
to NMS repricing will receive a new timestamp, and will be displayed at
the original locking price.\5\
---------------------------------------------------------------------------

    \4\ Such orders will be ranked at the locking price at the time
they are received by the Matching System. As noted above, an order
sender is permitted to submit an instruction that only orders which
lock the NBBO at the time of order entry be subject to the repricing
process. Orders which cross the NBBO would be rejected back to the
order sender.
    \5\ Any ranking, display or acceptance will be in compliance
with applicable rules regarding minimum pricing increments. See,
Regulation NMS Rule 612.
---------------------------------------------------------------------------

    In order to promote compliance with recent amendments to Regulation
SHO,\6\ CHX Only sell short orders will only execute at one minimum
increment above the current NBB if the short sale price test
restrictions of Rule 201 of Regulation SHO are in effect for the
covered security, and no exemption to such restrictions is applicable.
A CHX Only order that, at the time of entry, could not be executed or
displayed based on Rule 201 of Regulation SHO will be repriced by the
Matching System at one minimum price variation above the current NBB
(``short sale repricing'' and together with NMS repricing, the
``repricing process'') if the short sale price test restriction under
Rule 201 of Regulation SHO is in effect for the covered security.\7\ A
CHX Only order subject to short sale repricing will not be readjusted
downward even if it could be displayed at a lower price without
violation of Rule 201 of Regulation SHO. Neither CHX Only orders marked
``short exempt'' nor CHX Only orders displayed by the Matching System
at a price above the then current NBB at the time of initial display
shall be subject to short sale repricing. If a CHX Only order is
eligible for the repricing process, it will be subject to both NMS
repricing and short sale repricing.
---------------------------------------------------------------------------

    \6\ See Exchange Act Release No. 61595 (Feb. 26, 2010), 75 FR
11232 (Mar. 10, 2010) (adopting amendments to Rule 201 and Rule
200(g) of Regulation SHO). Among other things, Rule 201 requires a
trading center to establish, maintain, and enforce written policies
and procedures reasonably designed to prevent the execution or
display of a short sale order of a covered security at a price that
is less than or equal to the current national best bid if the price
of that covered security decreases by 10% or more from its previous
day's closing price. The amendment to Rule 200(g) provides a ``short
exempt'' marking requirement. The compliance date for the amendments
to Regulation SHO was February 28, 2011. See, Exchange Act Release
No. 63247 (Nov. 4, 2010), 75 FR 68702 (Nov. 9, 2010). See also,
Division of Trading & Markets, Responses to Frequently Asked
Questions Concerning Rule 201 of Regulation SHO.
    \7\ See 17 CFR 242.201(a)(1). Under Rule 201, the term ``covered
security'' means any ``NMS stock,'' as defined in Rule 600(b)(47) of
Regulation NMS. See, 17 CFR 242.600(b)(47).
---------------------------------------------------------------------------

    An example illustrates how the CHX Only order type would function.
Suppose that the prevailing market for security XYZ (which is a
security subject to the provisions of Regulation NMS and Regulation
SHO) is $30.25 (bid)--$30.26 (offered) and the best priced bid in the
Matching System is priced at $30.23. A CHX Only order to sell 100
shares of XYZ at $30.24 is submitted to the Matching System.\8\ Since
the order is not immediately executable within our system and the
display of the sell order at $30.24 would result in an impermissible
crossed market, the inbound sell would normally be cancelled and
rejected back to the order sender or routed to another destination
according to each Participant's instructions pursuant to the provisions
of Article 20, Rule 8(h). Pursuant to the NMS repricing process, a CHX
Only sell order would be repriced at the locking price (i.e., $30.25 in
this instance) for purposes of ranking within the CHX book. The
Matching System would publicly display the sell order at $30.26 in
order to avoid locking the market in violation of Rule 6 of Article 20
(Locked and Crossed Markets). If a buy order was submitted which could
be executed against the resting CHX Only order (i.e., the buy order was
priced at $30.25 or above), it would execute at the price at which the
CHX Only sell order was ranked within the Matching System, or $30.25 in
this example.
---------------------------------------------------------------------------

    \8\ This example assumes the order to sell is either long or
short, when the short sale price test restriction is not in effect.
---------------------------------------------------------------------------

    If the CHX Only order was a non-exempt sell short order and the
short sale price test restrictions of Rule 201 of Regulation SHO were
in effect for that security, then the order would have been ranked and
displayed at one minimum increment above the current NBB at the time of
receipt, in this case $30.26. Thus, the subsequent submission of a buy
limit order priced at $30.25 would not result in a match, and the buy
order would normally be displayed in the Matching System at $30.25.
Only a buy order priced at $30.26 or above would result in a
transaction by matching against the displayed CHX Only sell short
order.
    By submitting CHX Only orders, Participants will be able to avoid
the risk that their orders will be routed away or rejected because of
changes in the state of the national market system during the process
of order transmission. In addition, the use of the CHX Only order type
in connection with a sell short order will promote compliance with Rule
201 of Regulation SHO since non-exempt CHX Only sell short orders
priced at or below the current NBB would be repriced to one increment
above the current NBB.\9\ Moreover, the execution of CHX Only orders in
certain circumstances (such as the example noted above) will result in
price improvement above the displayed bid or offer for inbound orders.
CHX notes that order types similar to the CHX Only order are already in
use by other market centers.\10\
---------------------------------------------------------------------------

    \9\ Non-CHX Only sell short orders submitted with a limit price
at or below the current NBB at the time received by the Matching
System and which are not marked as sell short exempt shall be
cancelled and rejected back to the order sender.
    \10\ See, e.g., BATS Rule 11.9(c)(4) (BATS Only order) and EDGX
Rule 11.5(c)(4) (EDGX Only order). See also, Exchange Act Release
No. 63948 (Feb. 23, 2011), 76 FR 11303 (Mar. 1, 2011) (adopting the
short sale price sliding process for BATS Only orders). See also,
BATS Rule 11.9(c)(4), (g); EDGX Rule 11.5(c)(4)(B).
---------------------------------------------------------------------------

    The Exchange is also amending Rule 8 of Article 20 to describe how
the Matching System will process sell short orders in light of the
recent adoption of the short sale price test restrictions of Regulation
SHO. For any execution or display of a short sale order in a covered
security to occur on the Exchange when a short sale price test
restriction is in effect, the price must be above the current NBB,
unless the sell order was initially displayed by the Matching System at
a price above the then-current NBB or is marked ``short exempt''
pursuant to Regulation SHO.\11\ A short sale order, other than a CHX
Only order (which will be repriced), will be cancelled back to the
order sender if, based on Rule 201 of Regulation SHO, such order is not
executable, cannot be routed to another trading center pursuant to
Article 20, Rule 8(h) below and cannot be posted to the Matching
System. These provisions apply to all orders submitted to the Matching
System.
---------------------------------------------------------------------------

    \11\ Do Not Display sell short orders will not be accepted by
the Matching System if at the time of receipt the limit price is at
or below the current NBB, and no exception applies.
---------------------------------------------------------------------------

2. Statutory Basis
    The Exchange believes that the proposed rule change is consistent
with Section 6(b) of the Act in general,\12\ and furthers the
objectives of Section 6(b)(5) in particular,\13\ in that it is designed
to promote just and equitable principles of trade, to foster
cooperation and coordination with persons engaged in facilitating
transaction in securities, to remove impediments and perfect the
mechanisms of a free and open market, and, in general, to protect
investors and the public interest by allowing CHX to amend its rules to
add the CHX Only

order types based on similar rules already in effect at other
exchanges.
---------------------------------------------------------------------------

    \12\ 15 U.S.C. 78f(b).
    \13\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

    As noted above, CHX Only orders are designed to encourage displayed
liquidity on the Exchange and reduce automatic cancellations by the
Exchange's core trading facility, the Matching System, for orders which
lock or cross the best displayed quotes in the National Market System.
CHX Only orders will be automatically repriced by the Exchange's
systems on behalf of order senders. Participants will not have to
reenter orders which otherwise would have been cancelled and rejected
by the Exchange's systems to avoid prohibited locked or crossed markets
and trade throughs, therefore reducing messaging traffic and
facilitating the speedy representation of such orders in the national
market system. The use of the CHX Only order will also facilitate
compliance with the short sale price test restrictions of Regulation
SHO. Again, Participants will not have to reenter sell short orders
which would have been rejected by the Matching System if they were at
or below the current NBB at the time when they were received, and no
exception to the short sale price test restrictions applied. The
Exchange notes that other market centers, such as the BATS exchanges
and Direct Edge exchanges, have order types which make use of the
repricing process. The addition of these order types is intended to
benefit Exchange customers by reducing message traffic and improving
fill rates and promote competition among market centers offering
similar products and services.

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments Regarding the
Proposed Rule Change Received From Members, Participants or Others

    No written comments were either solicited or received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The Exchange has filed the proposed rule change pursuant to Section
19(b)(3)(A)(iii) of the Act \14\ and Rule 19b-4(f)(6) thereunder.\15\
Because the proposed rule change does not: (i) Significantly affect the
protection of investors or the public interest; (ii) impose any
significant burden on competition; and (iii) become operative prior to
30 days from the date on which it was filed, or such shorter time as
the Commission may designate, if consistent with the protection of
investors and the public interest, the proposed rule change has become
effective pursuant to Section 19(b)(3)(A) of the Act \16\ and Rule 19b-
4(f)(6) thereunder.\17\
---------------------------------------------------------------------------

    \14\ 15 U.S.C. 78s(b)(3)(A)(iii).
    \15\ 17 CFR 240.19b-4(f)(6).
    \16\ 15 U.S.C. 78s(b)(3)(A).
    \17\ 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

    A proposed rule change filed under Rule 19b-4(f)(6) \18\ normally
may not become operative prior to 30 days after the date of filing.\19\
However, Rule 19b-4(f)(6)(iii) permits the Commission to designate a
shorter time if such action is consistent with the protection of
investors and the public interest. The Exchange has requested that the
Commission waive the 30-day operative delay. The Commission believes
that waiving the 30-day operative delay is consistent with the
protection of investors and the public interest. Other national
securities exchanges have adopted similar order types,\20\ and this
proposal does not raise any novel issues. For these reasons, the
Commission designates the proposed rule change to be operative upon
filing with the Commission.\21\
---------------------------------------------------------------------------

    \18\ Id.
    \19\ 17 CFR 240.19b-4(f)(6)(iii). In addition, Rule 19b-
4(f)(6)(iii) requires that a self-regulatory organization submit to
the Commission written notice of its intent to file the proposed
rule change, along with a brief description and text of the proposed
rule change, at least five business days prior to the date of filing
of the proposed rule change, or such shorter time as designated by
the Commission. The Exchange has satisfied this requirement.
    \20\ See BATS Rule 11.9(c)(4) (BATS Only order), (g) (price
sliding); EDGX Rule 11.5(c)(4) (EDGX Only order).
    \21\ For the purposes only of waiving the 30-day operative
delay, the Commission has considered the proposed rule's impact on
efficiency, competition, and capital formation. See 15 U.S.C.
78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an e-mail to<EMAIL_ADDRESS>Please include
File Number SR-CHX-2011-04 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-CHX-2011-04. This file
number should be included on the subject line if e-mail is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for Web site viewing and
printing in the Commission's Public Reference Room, on official
business days between the hours of 10 a.m. and 3 p.m. Copies of the
filing also will be available for inspection and copying at the
principal office of the Exchange. All comments received will be posted
without change; the Commission does not edit personal identifying
information from submissions. You should submit only information that
you wish to make available publicly. All submissions should refer to
File Number SR-CHX-2011-04 and should be submitted on or before May 18,
2011.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\22\
---------------------------------------------------------------------------

    \22\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Cathy H. Ahn,
Deputy Secretary.
[FR Doc. 2011-10099 Filed 4-26-11; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 80, Number 245 (Tuesday, December 22, 2015)]
[Notices]
[Pages 79588-79589]
[FR Doc No: 2015-32130]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 14737-000]

Energy Resources USA Inc.; Notice of Preliminary Permit
Application Accepted for Filing and Soliciting Comments, Motions To
Intervene, and Competing Applications

    On November 26, 2015, Energy Resources USA Inc., filed an
application for a preliminary permit, pursuant to section 4(f) of the
Federal Power Act (FPA), proposing to study the feasibility of a
hydropower project to be located at the U.S. Army Corps of Engineers'
(Corps) Tom Bevill Lock and Dam on the Tombigbee River near the town of
Aliceville in Pickens County, Alabama. The sole purpose of a
preliminary permit, if issued, is to grant the permit holder priority
to file a license application during the permit term. A preliminary
permit does not authorize the permit holder to perform any land-
disturbing activities or otherwise enter upon lands or waters owned by
others without the owners' express permission.
    The proposed project would consist of the following: (1) A 770-
foot-long, 300-foot-wide intake channel with a 85-foot-long retaining
wall; (2) a 131-foot-long, 82-foot-wide powerhouse containing four
generating units with a total capacity of 15.5 megawatts; (3) a 1000-
foot-long, 220-foot-wide tailrace with a 40-foot-long retaining wall;
(4) a 4.16/69 kilo-Volt (kV) substation; and (5) a 3-mile-long, 69 kV
transmission line. The proposed project would have an estimated average
annual generation of 84,440 megawatt-hours, and operate as directed by
the Corps.
    Applicant Contact: Mr. Ander Gonzalez, Energy Resources USA Inc.,
2655 Le Jeune Road, Suite 804, Coral Gables, Florida 33134; Phone:
(954) 248-8425; Email<EMAIL_ADDRESS>    FERC Contact: Christiane Casey<EMAIL_ADDRESS>(202)
502-8577.
    Deadline for filing comments, motions to intervene, competing
applications (without notices of intent), or notices of intent to file
competing applications: 60 days from the issuance of this notice.
Competing applications and notices of intent must meet the requirements
of 18 CFR 4.36.
    The Commission strongly encourages electronic filing. Please file
comments, motions to intervene, notices of intent, and competing
applications using the Commission's eFiling system at http://www.ferc.gov/docs-filing/efiling.asp.

Commenters can submit brief comments up to 6,000 characters, without
prior registration, using the eComment system at http://www.ferc.gov/docs-filing/ecomment.asp. You must include your name and contact
information at the end of your comments. For assistance, please contact
FERC Online Support at<EMAIL_ADDRESS>(866) 208-3676 (toll
free), or<PHONE_NUMBER> (TTY). In lieu of electronic filing, please
send a paper copy to: Secretary, Federal Energy Regulatory Commission,
888 First Street NE., Washington, DC 20426. The first page of any
filing should include docket number P-14737-000.
    More information about this project, including a copy of the
application, can be viewed or printed on the ``eLibrary'' link of
Commission's Web site at http://www.ferc.gov/docs-filing/elibrary.asp.
Enter the docket number (P-14737) in the docket number field to access
the document. For assistance, contact FERC Online Support.

    Dated: December 16, 2015.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2015-32130 Filed 12-21-15; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register Volume 88, Number 145 (Monday, July 31, 2023)]
[Notices]
[Pages 49479-49482]
[FR Doc No: 2023-16142]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Docket ID FEMA-2023-0002; Internal Agency Docket No. FEMA-B-2357]

Proposed Flood Hazard Determinations

AGENCY: Federal Emergency Management Agency, Department of Homeland
Security.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Comments are requested on proposed flood hazard
determinations, which may include additions or modifications of any
Base Flood Elevation (BFE), base flood depth, Special Flood Hazard Area
(SFHA) boundary or zone designation, or regulatory floodway on the
Flood Insurance Rate Maps (FIRMs), and where applicable, in the
supporting Flood Insurance Study (FIS) reports for the communities
listed in the table below. The purpose of this notice is to seek
general information and comment regarding the preliminary FIRM, and
where applicable, the FIS report that the Federal Emergency Management
Agency (FEMA) has provided to the affected communities. The FIRM and
FIS report are the basis of the floodplain management measures that the
community is required either to adopt or to show evidence of having in
effect in order to qualify or remain qualified for participation in the
National Flood Insurance Program (NFIP).

DATES: Comments are to be submitted on or before October 30, 2023.

ADDRESSES: The Preliminary FIRM, and where applicable, the FIS report
for each community are available for inspection at both the online
location https://hazards.fema.gov/femaportal/prelimdownload and the
respective Community Map Repository address listed in the tables below.
Additionally, the current effective FIRM and FIS report for each
community are accessible online through the FEMA Map Service Center at
https://msc.fema.gov for comparison.
    You may submit comments, identified by Docket No. FEMA-B-2357, to
Rick Sacbibit, Chief, Engineering Services Branch, Federal Insurance
and Mitigation Administration, FEMA, 400 C Street SW, Washington, DC
20472,<PHONE_NUMBER>, or (email) [email protected].

FOR FURTHER INFORMATION CONTACT: Rick Sacbibit, Chief, Engineering
Services Branch, Federal Insurance and Mitigation Administration, FEMA,
400 C Street SW, Washington, DC 20472,<PHONE_NUMBER>, or (email)
[email protected]; or visit the FEMA Mapping and Insurance
eXchange (FMIX) online at https://www.floodmaps.fema.gov/fhm/fmx_main.html.

SUPPLEMENTARY INFORMATION: FEMA proposes to make flood hazard
determinations for each community listed below, in accordance with
section 110 of the Flood Disaster Protection Act of 1973, 42 U.S.C.
4104, and 44 CFR 67.4(a).
    These proposed flood hazard determinations, together with the
floodplain management criteria required by 44 CFR 60.3, are the minimum
that are required. They should not be construed to mean that the
community must change any existing ordinances that are more stringent
in their floodplain management requirements. The community may at any
time enact stricter requirements of its own or pursuant to policies
established by other Federal, State, or regional entities. These flood
hazard determinations are used to meet the floodplain management
requirements of the NFIP.
    The communities affected by the flood hazard determinations are
provided in the tables below. Any request for reconsideration of the
revised flood hazard information shown on the Preliminary FIRM and FIS
report that satisfies the data requirements outlined in 44 CFR 67.6(b)
is considered an appeal. Comments unrelated to the flood hazard
determinations also will be considered before the FIRM and FIS report
become effective.
    Use of a Scientific Resolution Panel (SRP) is available to
communities in support of the appeal resolution process. SRPs are
independent panels of experts in hydrology, hydraulics, and other
pertinent sciences established to review conflicting scientific and
technical data and provide recommendations for resolution. Use of the
SRP only may be exercised after FEMA and local communities have been
engaged in a collaborative consultation process for at least 60 days
without a mutually acceptable resolution of an appeal. Additional
information regarding the SRP process can be found online at https://www.floodsrp.org/pdfs/srp_overview.pdf.
    The watersheds and/or communities affected are listed in the tables
below. The Preliminary FIRM, and where applicable, FIS report for each
community are available for inspection at both the online location
https://hazards.fema.gov/femaportal/

prelimdownload and the respective Community Map Repository address
listed in the tables. For communities with multiple ongoing Preliminary
studies, the studies can be identified by the unique project number and
Preliminary FIRM date listed in the tables. Additionally, the current
effective FIRM and FIS report for each community are accessible online
through the FEMA Map Service Center at https://msc.fema.gov for
comparison.

(Catalog of Federal Domestic Assistance No. 97.022, ``Flood
Insurance.'')

Nicholas A. Shufro,
Deputy Assistant Administrator for Risk Management, Federal Emergency
Management Agency, Department of Homeland Security.

------------------------------------------------------------------------
                                             Community map repository
               Community                             address
------------------------------------------------------------------------
             Essex County, Massachusetts (All Jurisdictions)
           Project: 15-01-0633S Preliminary Date: May 26, 2023
------------------------------------------------------------------------
City of Beverly........................  City Hall, 191 Cabot Street,
                                          Beverly, MA 01915.
City of Gloucester.....................  City Hall, 9 Dale Avenue,
                                          Gloucester, MA 01930.
City of Haverhill......................  City Hall, 4 Summer Street,
                                          Haverhill, MA 01830.
City of Lynn...........................  City Hall, 3 City Hall Square,
                                          Lynn, MA 01901.
City of Newburyport....................  City Hall, 60 Pleasant Street,
                                          Newburyport, MA 01950.
City of Peabody........................  City Hall, 24 Lowell Street,
                                          Peabody, MA 01960.
City of Salem..........................  City Hall, 93 Washington
                                          Street, Salem, MA 01970.
Town of Andover........................  Town Hall, 36 Bartlet Street,
                                          Andover, MA 01810.
Town of Boxford........................  Town Hall, 7A Spofford Road,
                                          Boxford, MA 01921.
Town of Danvers........................  Town Hall, 1 Sylvan Street,
                                          Danvers, MA 01923.
Town of Essex..........................  Town Hall, 30 Martin Street,
                                          Essex, MA 01929.
Town of Georgetown.....................  Town Hall, 1 Library Street,
                                          Georgetown, MA 01833.
Town of Groveland......................  Town Hall, 183 Main Street,
                                          Groveland, MA 01834.
Town of Hamilton.......................  Town Hall, 577 Bay Road,
                                          Hamilton, MA 01936.
Town of Ipswich........................  Town Hall, 25 Green Street,
                                          Ipswich, MA 01938.
Town of Lynnfield......................  Town Hall, 55 Summer Street,
                                          Lynnfield, MA 01940.
Town of Manchester-by-the-Sea..........  Town Hall, 10 Central Street,
                                          Manchester-by-the-Sea, MA
                                          01944.
Town of Marblehead.....................  Abbot Hall, 188 Washington
                                          Street, Marblehead, MA 01945.
Town of Merrimac.......................  Town Hall, 4 School Street,
                                          Merrimac, MA 01860.
Town of Middleton......................  Town Hall, 48 South Main
                                          Street, Middleton, MA 01949.
Town of Newbury........................  Newbury Municipal Offices, 12
                                          Kent Way, Byfield, MA 01922.
Town of North Andover..................  Town Hall, 120 Main Street,
                                          North Andover, MA 01845.
Town of Rockport.......................  Town Hall, 34 Broadway,
                                          Rockport, MA 01966.
Town of Rowley.........................  Town Hall, 139 Main Street,
                                          Rowley, MA 01969.
Town of Saugus.........................  Town Hall, 298 Central Street,
                                          Saugus, MA 01906.
Town of Swampscott.....................  Town Hall, 22 Monument Avenue,
                                          Swampscott, MA 01907.
Town of Topsfield......................  Town Offices, 8 West Common
                                          Street, Topsfield, MA 01983.
Town of Wenham.........................  Town Hall, 138 Main Street,
                                          Wenham, MA 01984.
Town of West Newbury...................  Town Hall, 381 Main Street,
                                          West Newbury, MA 01985.
------------------------------------------------------------------------
           Middlesex County, Massachusetts (All Jurisdictions)
          Project: 15-01-0633S Preliminary Date: June 08, 2023
------------------------------------------------------------------------
City of Cambridge......................  City Hall, 795 Massachusetts
                                          Avenue, Cambridge, MA 02139.
City of Everett........................  City Hall, 484 Broadway,
                                          Everett, MA 02149.
City of Lowell.........................  City Hall, 375 Merrimack
                                          Street, Lowell, MA 01852.
City of Malden.........................  City Hall, 200 Pleasant Street,
                                          Malden, MA 02148.
City of Medford........................  City Hall, 85 George P. Hassett
                                          Drive, Medford, MA 02155.
City of Melrose........................  City Hall, 562 Main Street,
                                          Melrose, MA 02176.
City of Newton.........................  City Hall, 1000 Commonwealth
                                          Avenue, Newton, MA 02459.
City of Somerville.....................  City Hall, 93 Highland Avenue,
                                          Somerville, MA 02143.
City of Waltham........................  City Hall, 610 Main Street,
                                          Waltham, MA 02452.
City of Woburn.........................  City Hall, 10 Common Street,
                                          Woburn, MA 01801.
Town of Arlington......................  Town Hall, 730 Massachusetts
                                          Avenue, Arlington, MA 02476.
Town of Ashby..........................  Town Hall, 895 Main Street,
                                          Ashby, MA 01431.
Town of Ashland........................  Town Hall, 101 Main Street,
                                          Ashland, MA 01721.
Town of Ayer...........................  Town Hall, 1 Main Street, Ayer,
                                          MA 01432.
Town of Bedford........................  Town Hall, 10 Mudge Way,
                                          Bedford, MA 01730.
Town of Belmont........................  Town Hall, 455 Concord Avenue,
                                          Belmont, MA 02478.
Town of Billerica......................  Town Hall, 365 Boston Road,
                                          Billerica, MA 01821.
Town of Boxborough.....................  Town Hall, 29 Middle Road,
                                          Boxborough, MA 01719.
Town of Burlington.....................  Town Hall, 29 Center Street,
                                          Burlington, MA 01803.
Town of Chelmsford.....................  Town Hall, 50 Billerica Road,
                                          Chelmsford, MA 01824.
Town of Concord........................  Town House, 22 Monument Square,
                                          Concord, MA 01742.
Town of Dracut.........................  Town Hall, 62 Arlington Street,
                                          Dracut, MA 01826.
Town of Dunstable......................  Town Hall, 511 Main Street,
                                          Dunstable, MA 01827.
Town of Groton.........................  Town Hall, 173 Main Street,
                                          Groton, MA 01450.
Town of Holliston......................  Town Hall, 703 Washington
                                          Street, Holliston, MA 01746.
Town of Hopkinton......................  Town Hall, 18 Main Street,
                                          Hopkinton, MA 01748.
Town of Lexington......................  Town Offices, 1625
                                          Massachusetts Avenue,
                                          Lexington, MA 02420.
Town of Lincoln........................  Town Hall, 16 Lincoln Road,
                                          Lincoln, MA 01773.
Town of Littleton......................  Town Hall, 37 Shattuck Street,
                                          Littleton, MA 01460.

Town of Natick.........................  Town Hall, 13 East Central
                                          Street, Natick, MA 01760.
Town of North Reading..................  Town Hall, 235 North Street,
                                          North Reading, MA 01864.
Town of Pepperell......................  Town Hall, 1 Main Street,
                                          Pepperell, MA 01463.
Town of Reading........................  Town Hall, 16 Lowell Street,
                                          Reading, MA 01867.
Town of Sherborn.......................  Town Hall, 19 Washington
                                          Street, Sherborn, MA 01770.
Town of Shirley........................  Town Hall, 7 Keady Way,
                                          Shirley, MA 01464.
Town of Stoneham.......................  Town Hall, 35 Central Street,
                                          Stoneham, MA 02180.
Town of Tewksbury......................  Town Hall, 1009 Main Street,
                                          Tewksbury, MA 01876.
Town of Townsend.......................  Town Hall, 272 Main Street,
                                          Townsend, MA 01469.
Town of Tyngsborough...................  Town Hall, 25 Bryants Lane,
                                          Tyngsborough, MA 01879.
Town of Wakefield......................  Town Hall, 1 Lafayette Street,
                                          Wakefield, MA 01880.
Town of Watertown......................  Town Hall, 149 Main Street,
                                          Watertown, MA 02472.
Town of Wayland........................  Town Hall, 41 Cochituate Road,
                                          Wayland, MA 01778.
Town of Westford.......................  Town Hall, 55 Main Street,
                                          Westford, MA 01886.
Town of Weston.........................  Town Hall, 11 Town House Road,
                                          Weston, MA 02493.
Town of Wilmington.....................  Town Hall, 121 Glen Road,
                                          Wilmington, MA 01887.
Town of Winchester.....................  Town Hall, 71 Mt. Vernon
                                          Street, Winchester, MA 01890.
------------------------------------------------------------------------
            Norfolk County, Massachusetts (All Jurisdictions)
          Project: 15-01-0633S Preliminary Date: April 07, 2023
------------------------------------------------------------------------
City of Quincy.........................  City Hall, 1305 Hancock Street,
                                          Quincy, MA 02169.
Town of Avon...........................  Town Hall, 65 East Main Street,
                                          Avon, MA 02322.
Town of Bellingham.....................  Municipal Center, 10 Mechanic
                                          Street, Bellingham, MA 02019.
Town of Braintree......................  Town Hall, 1 John F. Kennedy
                                          Memorial Drive, Braintree, MA
                                          02184.
Town of Brookline......................  Town Hall, 333 Washington
                                          Street, Brookline, MA 02445.
Town of Canton.........................  Town Hall, 801 Washington
                                          Street, Canton, MA 02021.
Town of Cohasset.......................  Town Hall, 41 Highland Avenue,
                                          Cohasset, MA 02025.
Town of Dedham.........................  Town Hall, 450 Washington
                                          Street, Dedham, MA 02026.
Town of Dover..........................  Town House, 5 Springdale
                                          Avenue, Dover, MA 02030.
Town of Foxborough.....................  Town Hall, 40 South Street,
                                          Foxborough, MA 02035.
Town of Franklin.......................  Town Hall, 355 East Central
                                          Street, Franklin, MA 02038.
Town of Holbrook.......................  Town Hall, 50 North Franklin
                                          Street, Holbrook, MA 02343.
Town of Medfield.......................  Town House, 459 Main Street,
                                          Medfield, MA 02052.
Town of Medway.........................  Town Hall, 155 Village Street,
                                          Medway, MA 02053.
Town of Millis.........................  Veterans Memorial Building, 900
                                          Main Street, Millis, MA 02054.
Town of Milton.........................  Town Office Building, 525
                                          Canton Avenue, Milton, MA
                                          02186.
Town of Needham........................  Town Hall, 1471 Highland
                                          Avenue, Needham, MA 02492.
Town of Norfolk........................  Town Hall, 1 Liberty Lane,
                                          Norfolk, MA 02056.
Town of Norwood........................  Town Hall, 566 Washington
                                          Street, Norwood, MA 02062.
Town of Plainville.....................  Town Hall, 142 South Street,
                                          Plainville, MA 02762.
Town of Randolph.......................  Town Hall, 41 South Main
                                          Street, Randolph, MA 02368.
Town of Sharon.........................  Town Office Building, 90 South
                                          Main Street, Sharon, MA 02067.
Town of Stoughton......................  Town Hall, 10 Pearl Street,
                                          Stoughton, MA 02072.
Town of Walpole........................  Town Hall, 135 School Street,
                                          Walpole, MA 02081.
Town of Wellesley......................  Town Hall, 888 Worcester
                                          Street, Wellesley, MA 02482.
Town of Westwood.......................  Town Hall, 580 High Street,
                                          Westwood, MA 02090.
Town of Weymouth.......................  Town Hall, 75 Middle Street,
                                          Weymouth, MA 02189.
Town of Wrentham.......................  Town Hall, 79 South Street,
                                          Wrentham, MA 02093.
------------------------------------------------------------------------
           Worcester County, Massachusetts (All Jurisdictions)
           Project: 16-01-0276S Preliminary Date: May 05, 2023
------------------------------------------------------------------------
City of Fitchburg......................  City Hall, 718 Main Street,
                                          Fitchburg, MA 01420.
City of Gardner........................  City Hall, 95 Pleasant Street,
                                          Gardner, MA 01440.
City of Leominster.....................  City Hall, 25 West Street,
                                          Leominster, MA 01453.
City of Worcester......................  City Hall, 455 Main Street,
                                          Worcester, MA 01608.
Town of Ashburnham.....................  Town Hall, 32 Main Street,
                                          Ashburnham, MA 01430.
Town of Berlin.........................  Town Offices, 23 Linden Street,
                                          Berlin, MA 01503.
Town of Bolton.........................  Town Hall, 663 Main Street,
                                          Bolton, MA 01740.
Town of Boylston.......................  Town Hall, 221 Main Street,
                                          Boylston, MA 01505.
Town of Clinton........................  Town Hall, 242 Church Street,
                                          Clinton, MA 01510.
Town of Harvard........................  Town Hall, 13 Ayer Road,
                                          Harvard, MA 01451.
Town of Holden.........................  Starbard Building, 1204 Main
                                          Street, Holden, MA 01520.
Town of Hopedale.......................  Town Office, 78 Hopedale
                                          Street, Hopedale, MA 01747.
Town of Hubbardston....................  Town Hall, 7 Main Street,
                                          Hubbardston, MA 01452.
Town of Lancaster......................  Prescott Building, 701 Main
                                          Street, Lancaster, MA 01523.
Town of Lunenburg......................  Town Hall, 17 Main Street,
                                          Lunenburg, MA 01462.
Town of Mendon.........................  Town Hall, 20 Main Street,
                                          Mendon, MA 01756.
Town of Milford........................  Town Hall, 52 Main Street,
                                          Milford, MA 01757.
Town of Paxton.........................  Town Hall, 697 Pleasant Street,
                                          Paxton, MA 01612.
Town of Princeton......................  Town Hall, 6 Town Hall Drive,
                                          Princeton, MA 01541.
Town of Rutland........................  Town Hall, 250 Main Street,
                                          Rutland, MA 01543.
Town of Sterling.......................  Butterick Municipal Building, 1
                                          Park Street, Sterling, MA
                                          01564.

Town of West Boylston..................  Town Hall, 140 Worcester
                                          Street, West Boylston, MA
                                          01583.
Town of Westminster....................  Town Hall, 11 South Street,
                                          Westminster, MA 01473.
------------------------------------------------------------------------

[FR Doc. 2023-16142 Filed 7-28-23; 8:45 am]
BILLING CODE 9110-12-P


[Federal Register Volume 79, Number 22 (Monday, February 3, 2014)]
[Notices]
[Page 6196]
[FR Doc No: 2014-02129]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP14-46-000]

Southwest Gas Storage Company; Notice of Request Under Blanket
Authorization

    Take notice that on January 16, 2014, Southwest Gas Storage Company
(Southwest), 1300 Main Street, Houston, Texas 77002, filed in Docket
No. CP14-46-000, an application pursuant to sections 157.205 and
157.216(b) of the Commission's Regulations under the Natural Gas Act
(NGA) as amended, requesting authorization to abandon in place an 1,100
horsepower (HP) compressor unit and related equipment, located at
Southwest's Waverly Storage Compressor Station in Morgan County,
Illinois. The authorizations are requested under Southwest's blanket
certificate issued in Docket No. CP99-230-000,\1\ all as more fully set
forth in the application which is on file with the Commission and open
to public inspection.
---------------------------------------------------------------------------

    \1\ See Southwest Gas Storage Co., 86 FERC ] 62,232 (1999).
---------------------------------------------------------------------------

    Southwest proposes to abandon in place the unit identified as W-10,
with appurtenances. This unit was installed under the authority granted
in FPC Docket No. CP71-73.\2\ ANR intends to abandon its unit W-10
because it does not anticipate needing it at its present location for
the foreseeable future, it has become increasingly expensive to
maintain. The proposed abandonment activity will not involve ground
disturbance or increases to operational air or noise emissions. The
unit has not been used for over twelve months. The estimated cost to
replicate the 1,100 HP compressor unit proposed to be abandoned is $8.5
million.
---------------------------------------------------------------------------

    \2\ See Panhandle Eastern Pipeline Company, 45 FPC 994 (1971).
---------------------------------------------------------------------------

    The filing may also be viewed on the web at http://www.ferc.gov
using the ``eLibrary'' link. Enter the docket number excluding the last
three digits in the docket number field to access the document. For
assistance, please contact FERC Online Support at
<EMAIL_ADDRESS>or toll free at<PHONE_NUMBER>, or TTY,
contact<PHONE_NUMBER>.
    Any questions concerning this application should be directed to
Stephen Veatch, Sr., Director of Certificates, Southwest Gas Storage
Company, 1300 Main Street, Houston, Texas, 77002, or call (713) 989-
2024, fax<PHONE_NUMBER>, or email<EMAIL_ADDRESS>    Any person or the Commission's staff may, within 60 days after
issuance of the instant notice by the Commission, file pursuant to Rule
214 of the Commission's Procedural Rules (18 CFR 385.214) a motion to
intervene or notice of intervention and pursuant to Section 157.205 of
the regulations under the NGA (18 CFR 157.205), a protest to the
request. If no protest is filed within the time allowed therefore, the
proposed activity shall be deemed to be authorized effective the day
after the time allowed for filing a protest. If a protest is filed and
not withdrawn within 30 days after the allowed time for filing a
protest, the instant request shall be treated as an application for
authorization pursuant to Section 7 of the NGA.
    Persons who wish to comment only on the environmental review of
this project should submit an original and two copies of their comments
to the Secretary of the Commission. Environmental commenter's will be
placed on the Commission's environmental mailing list, will receive
copies of the environmental documents, and will be notified of meetings
associated with the Commission's environmental review process.
Environmental commenter's will not be required to serve copies of filed
documents on all other parties. However, the non-party commentary, will
not receive copies of all documents filed by other parties or issued by
the Commission (except for the mailing of environmental documents
issued by the Commission) and will not have the right to seek court
review of the Commission's final order.
    The Commission strongly encourages electronic filings of comments,
protests and interventions in lieu of paper using the ``eFiling'' link
at http://www.ferc.gov. Persons unable to file electronically should
submit an original and 7 copies of the protest or intervention to the
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426.
    Comment date: March 28, 2014.

    Dated: January 27, 2014.
Kimberly D. Bose,
 Secretary.
[FR Doc. 2014-02129 Filed 1-31-14; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 86, Number 65 (Wednesday, April 7, 2021)]
[Notices]
[Pages 18051-18052]
[FR Doc No: 2021-07106]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER21-1519-000]

Cool Springs Solar, LLC; Supplemental Notice That Initial Market-
Based Rate Filing Includes Request for Blanket Section 204
Authorization

    This is a supplemental notice in the above-referenced Cool Springs
Solar, LLC's application for market-based rate authority, with an
accompanying rate tariff, noting that such application includes a
request for blanket authorization, under 18 CFR part 34, of future
issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE, Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability, is April 20, 2021.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://

www.ferc.gov. To facilitate electronic service, persons with internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically may mail similar pleadings to
the Federal Energy Regulatory Commission, 888 First Street NE,
Washington, DC 20426. Hand delivered submissions in docketed
proceedings should be delivered to Health and Human Services, 12225
Wilkins Avenue, Rockville, Maryland 20852.
    In addition to publishing the full text of this document in the
Federal Register, the Commission provides all interested persons an
opportunity to view and/or print the contents of this document via the
internet through the Commission's Home Page (http://www.ferc.gov) using
the ``eLibrary'' link. Enter the docket number excluding the last three
digits in the docket number field to access the document. At this time,
the Commission has suspended access to the Commission's Public
Reference Room, due to the proclamation declaring a National Emergency
concerning the Novel Coronavirus Disease (COVID-19), issued by the
President on March 13, 2020. For assistance, contact the Federal Energy
Regulatory Commission at<EMAIL_ADDRESS>or call toll-free,
(886) 208-3676 or TYY,<PHONE_NUMBER>.

    Dated: March 31, 2021.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2021-07106 Filed 4-6-21; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 79, Number 1 (Thursday, January 2, 2014)]
[Notices]
[Pages 120-121]
[FR Doc No: 2013-31400]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 3030-019]

Antrim County; Notice of Application Accepted for Filing, Ready
for Environmental Analysis, and Soliciting Motions To Intervene and
Protests, Comments, Recommendations, Terms and Conditions, and
Prescriptions

    Take notice that the following hydroelectric application has been
filed with the Commission and is available for public inspection.
    a. Type of Application: Subsequent license.
    b. Project No.: 3030-019.
    c. Date filed: December 21, 2012.
    d. Applicant: Antrim County.
    e. Name of Project: Elk Rapids Hydroelectric Project.
    f. Location: On the Elk River, in the village of Elk Rapids, the
counties of Antrim, Grand Traverse, and Kalkaskia, Michigan. The
project does not occupy any federal lands.
    g. Filed Pursuant to: Federal Power Act 16 U.S.C. 791(a)-825(r).
    h. Applicant Contact: Willam Stockhausen, Elk Rapids Hydroelectric
Power, LLC, 218 West Dunlap Street, Northville, MI 48167 or at (248)
349-2833.
    i. FERC Contact: Lee Emery,<PHONE_NUMBER><EMAIL_ADDRESS>    j. Deadline for filing motions to intervene and protests, comments,
recommendations, terms and conditions, and prescriptions: 60 days from
the issuance date of this notice; reply comments are due 105 days from
the issuance date of this notice.
    The Commission strongly encourages electronic filing. Please file
comments, recommendations, terms and conditions, and prescriptions
using the Commission's eFiling system at http://www.ferc.gov/docs-filing/efiling.asp. Commenters can submit brief comments up to 6,000
characters, without prior registration, using the eComment system at
http://www.ferc.gov/docs-filing/ecomment.asp. You must include your
name and contact information at the end of your comments. For
assistance, please contact FERC Online Support at
<EMAIL_ADDRESS>(866) 208-3676 (toll free), or (202) 502-
8659 (TTY). In lieu of electronic filing, please send a paper copy to:
Secretary, Federal Energy Regulatory Commission, 888 First Street NE.,
Washington, DC 20426. The first page of any filing should include
docket number P-3030-019.
    The Commission's Rules of Practice require all intervenors filing
documents with the Commission to serve a copy of that document on each
person on the official service list for the project. Further, if an
intervenor files comments or documents with the Commission relating to
the merits of an issue that may affect the responsibilities of a
particular resource agency, they must also serve a copy of the document
on that resource agency.
    k. This application has been accepted, and is ready for
environmental analysis at this time.
    l. The Elk Rapids Project consists of: (1) Two impoundments, the
2,560-acre Skegemog Lake and the 7,730-acre Elk Lake; (2) a 121-foot-
long, 52-foot-high, 26-foot-wide existing powerhouse that spans the
main channel of the Elk River, with an operating head of 10.5 feet; (3)
a 24-foot-high, single story superstructure; (4) a substructure that
includes the intakes and turbine pits, which are about 13 feet high;
(5) a 13-foot-high concrete foundation located below the substructure
that incorporates the draft tubes; (6) four intake bays, each 22 feet
wide with sliding head gates at the powerhouse wall; (7) two Francis
turbines, each with an installed capacity of 350 kilowatts; (8) intake
trash racks having a 1.75-inch clear bar spacing; (9) a 14-foot-wide
overflow spillway located about 400 feet south of the powerhouse, which
consists of two adjacent concrete drop structures, each with 7-foot-
long stop logs to control the lake level, with each drop structure
leading to a 62.5-foot-long by 4.5-foot-diameter culvert that passes
under Dexter Street; (10) two turbine gates used to spill excess water
through the two intake bays that do not contain turbines and generating
units; (11) a 4,160-kilovolt (kV) transmission line that extends about
30 feet from the powerhouse to a 20-foot by 30-foot substation
enclosure; (12) a 50-foot-long underground 12.5-kV transmission line to
connect the project substation to the local utility distribution lines;
and (13) other appurtenant facilities. The average annual generation is
estimated to be 2,422 megawatt-hours (MWh).
    m. A copy of the application is available for review at the
Commission in the Public Reference Room or may be viewed on the
Commission's Web site at http://www.ferc.gov using the ``eLibrary''
link. Enter the docket number excluding the last three digits in the
docket number field to access the document. For assistance, contact
FERC Online Support. A copy is also available

for inspection and reproduction at the address in item h above.
    n. Anyone may submit comments, a protest, or a motion to intervene
in accordance with the requirements of Rules of Practice and Procedure,
18 CFR 385.210, .211, and .214. In determining the appropriate action
to take, the Commission will consider all protests or other comments
filed, but only those who file a motion to intervene in accordance with
the Commission's Rules may become a party to the proceeding. Any
comments, protests, or motions to intervene must be received on or
before the specified comment date for the particular application.
    All filings must (1) bear in all capital letters the title
``PROTEST'', ``MOTION TO INTERVENE'', ``COMMENTS'', ``REPLY COMMENTS'',
``RECOMMENDATIONS'', ``TERMS AND CONDITIONS'', or ``PRESCRIPTIONS'';
(2) set forth in the heading the name of the applicant and the project
number of the application to which the filing responds; (3) furnish the
name, address, and telephone number of the person protesting or
intervening; and (4) otherwise comply with the requirements of 18 CFR
385.2001 through 385.2005. All comments, recommendations, terms and
conditions or prescriptions must set forth their evidentiary basis and
otherwise comply with the requirements of 18 CFR 4.34(b). Agencies may
obtain copies of the application directly from the applicant. A copy of
any protest or motion to intervene must be served upon each
representative of the applicant specified in the particular
application. A copy of all other filings in reference to this
application must be accompanied by proof of service on all persons
listed in the service list prepared by the Commission in this
proceeding, in accordance with 18 CFR 4.34(b) and 385.2010.
    You may also register online at http://www.ferc.gov/docs-filing/esubscription.asp to be notified via email of new filings and issuances
related to this or other pending projects. For assistance, contact FERC
Online Support.
    o. A license applicant must file no later than 60 days following
the date of issuance of this notice: (1) A copy of the water quality
certification; (2) a copy of the request for certification, including
proof of the date on which the certifying agency received the request;
or (3) evidence of waiver of water quality certification.

    Dated: December 26, 2013.
Kimberly D. Bose,
 Secretary.
[FR Doc. 2013-31400 Filed 12-31-13; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 86, Number 3 (Wednesday, January 6, 2021)]
[Notices]
[Page 539]
[FR Doc No: 2020-29248]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. EL21-33-000; QF86-381-002]

Citrus World, Inc.; Notice of Petition for Declaratory Order

    Take notice that on December 21, 2020, pursuant to Rule 207 of the
Federal Energy Regulatory Commission's (Commission) Rules of Practice
and Procedure, 18 CFR 385.207, Citrus World, Inc. (Petitioner), filed a
petition for declaratory order (Petition) requesting that the
Commission issue a declaratory order granting partial waiver of
Commission regulations applicable to cogeneration qualifying facilities
(excepting sections 205 and 206 of the Federal Power Act) and accepting
refund report, as more fully explained in the petition.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed on or before the comment date.
Anyone filing a motion to intervene or protest must serve a copy of
that document on the Petitioner.
    In addition to publishing the full text of this document in the
Federal Register, the Commission provides all interested persons an
opportunity to view and/or print the contents of this document via the
internet through the Commission's Home Page (http://ferc.gov) using the
eLibrary link. Enter the docket number excluding the last three digits
in the docket number field to access the document. At this time, the
Commission has suspended access to the Commission's Public Reference
Room, due to the proclamation declaring a National Emergency concerning
the Novel Coronavirus Disease (COVID-19), issued by the President on
March 13, 2020. For assistance, contact the Federal Energy Regulatory
Commission at<EMAIL_ADDRESS>or call toll-free, (886) 208-
3676 or TYY,<PHONE_NUMBER>.
    The Commission strongly encourages electronic filings of comments,
protests and interventions in lieu of paper using the eFiling link at
http://www.ferc.gov. Persons unable to file electronically may mail
similar pleadings to the Federal Energy Regulatory Commission, 888
First Street NE, Washington, DC 20426. Hand delivered submissions in
docketed proceedings should be delivered to Health and Human Services,
12225 Wilkins Avenue, Rockville, Maryland 20852.
    Comment Date: 5:00 p.m. Eastern time on January 11, 2021.

    Dated: December 30, 2020.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2020-29248 Filed 1-5-21; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 87, Number 235 (Thursday, December 8, 2022)]
[Notices]
[Pages 75278-75279]
[FR Doc No: 2022-26663]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2022-P-0585]

Determination That NORFLEX (Orphenadrine Citrate) Injection, 30
Milligrams/Milliliter, and NORFLEX (Orphenadrine Citrate) Extended-
Release Tablet, 100 Milligrams, Were Not Withdrawn From Sale for
Reasons of Safety or Effectiveness

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, Agency, or we) has
determined that NORFLEX (orphenadrine citrate) Injection, 30 milligrams
(mg)/milliliter (mL), and NORFLEX (orphenadrine citrate) Extended-
Release Tablet, 100 mg, were not withdrawn from sale for reasons of
safety or effectiveness. This determination means that FDA will not
begin procedures to withdraw approval of abbreviated new drug
applications (ANDAs) that refer to this drug product, and it will allow
FDA to continue to approve ANDAs that refer to the product as long as
they meet relevant legal and regulatory requirements.

FOR FURTHER INFORMATION CONTACT: Anuj Shah, Center for Drug Evaluation
and Research, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 51, Rm. 6224, Silver Spring, MD 20993-0002,<PHONE_NUMBER>,
[email protected].

SUPPLEMENTARY INFORMATION: Section 505(j) of the Federal Food, Drug,
and Cosmetic Act (FD&C Act) (21 U.S.C. 355(j)) allows the submission of
an ANDA to market a generic version of a previously approved drug
product. To obtain approval, the ANDA applicant must show, among other
things, that the generic drug product: (1) has the same active
ingredient(s), dosage form, route of administration, strength,
conditions of use, and (with certain exceptions) labeling as the listed
drug, which is a version of the drug that was previously approved and
(2) is bioequivalent to the listed drug. ANDA applicants do not have to
repeat the extensive clinical testing otherwise necessary to gain
approval of a new drug application (NDA).
    Section 505(j)(7) of the FD&C Act requires FDA to publish a list of
all approved drugs. FDA publishes this list as part of the ``Approved
Drug Products With Therapeutic Equivalence Evaluations,'' which is
known generally as the ``Orange Book.'' Under FDA regulations, drugs
are removed from the list if the Agency withdraws or suspends approval
of the drug's NDA or ANDA for reasons of safety or effectiveness or if
FDA determines that the listed drug was withdrawn from sale for reasons
of safety or effectiveness (21 CFR 314.162).
    A person may petition the Agency to determine, or the Agency may
determine on its own initiative, whether a listed drug was withdrawn
from sale for reasons of safety or effectiveness. This determination
may be made at any time after the drug has been withdrawn from sale,
but must be made prior to FDA's approval of an ANDA that refers to the
listed drug (Sec.  314.161 (21 CFR 314.161)). FDA may not approve an
ANDA that does not refer to a listed drug.
    NORFLEX (orphenadrine citrate) Injection, 30 mg/mL, is the subject
of NDA 013055, held by Pai Holdings LLC DBA Pharmaceutical Associates
Inc., and initially approved on October 2, 1960. NORFLEX (orphenadrine
citrate) Extended-Release Tablet, 100 mg, is the subject of NDA 012157,
held by Bausch Health US LLC, and initially approved on November 2,
1959. Both NORFLEX drug products are indicated as an adjunct to rest,
physical therapy, and other measures for the relief of discomfort
associated with acute painful musculoskeletal conditions.
    Both NORFLEX (orphenadrine citrate) Injection, 30 mg/mL, and
NORFLEX (orphenadrine citrate) Extended-Release Tablet, 100 mg, are
currently listed in the ``Discontinued Drug Product List'' section of
the Orange Book.
    Odin Pharmaceuticals, LLC, submitted a citizen petition dated April
11, 2022 (Docket No. FDA-2022-P-0585), under 21 CFR 10.30, requesting
that the Agency determine whether NORFLEX (orphenadrine citrate)
Injection, 30 mg/mL, was withdrawn from sale for reasons of safety or
effectiveness. Although the citizen petition did not address the 100 mg
extended-release tablet, that dosage form and strength has also been
discontinued. On our own initiative, we have also determined whether
that dosage form and strength was withdrawn for safety or effectiveness
reasons.
    After considering the citizen petition and reviewing Agency records
and based on the information we have at this time, FDA has determined
under Sec.  314.161 that NORFLEX (orphenadrine citrate) Injection, 30
mg/mL, and NORFLEX (orphenadrine citrate) Extended-Release Tablet, 100
mg, were not withdrawn for reasons of safety or effectiveness. The
petitioner has identified no data or other information suggesting that
these drug products were withdrawn for reasons of safety or
effectiveness. We have carefully reviewed our files for records
concerning the withdrawal of NORFLEX (orphenadrine citrate) Injection,
30 mg/mL, and NORFLEX (orphenadrine citrate) Extended-Release Tablet,
100 mg, from sale. We have also independently evaluated relevant
literature and data for possible postmarketing adverse events. We have
found no information that would indicate that these drug products were
withdrawn from sale for reasons of safety or effectiveness.
    Accordingly, the Agency will continue to list NORFLEX (orphenadrine
citrate) Injection, 30 mg/mL, and NORFLEX (orphenadrine citrate)
Extended-Release Tablet, 100 mg, in the ``Discontinued Drug Product
List'' section of the Orange Book. The ``Discontinued Drug Product
List'' delineates, among other items, drug products that have been
discontinued from marketing for reasons other than safety or
effectiveness. FDA will not begin procedures to withdraw approval of
approved ANDAs that refer to this drug product. Additional ANDAs for
this drug product may also be approved by the Agency as long as they
meet all other legal and regulatory requirements for the approval of
ANDAs. If FDA determines that labeling for this drug product should be
revised to meet

current standards, the Agency will advise ANDA applicants to submit
such labeling.

    Dated: December 5, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-26663 Filed 12-7-22; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 83, Number 30 (Tuesday, February 13, 2018)]
[Notices]
[Pages 6198-6199]
[FR Doc No: 2018-02868]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2015-E-2666; FDA-2015-E-2758; and FDA-2015-E-2664]

Determination of Regulatory Review Period for Purposes of Patent
Extension; FARYDAK

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or the Agency) has
determined the regulatory review period for FARYDAK and is publishing
this notice of that determination as required by law. FDA has made the
determination because of the submission of applications to the Director
of the U.S. Patent and Trademark Office (USPTO), Department of
Commerce, for the extension of a patent which claims that human drug
product.

DATES: Anyone with knowledge that any of the dates as published (in the
SUPPLEMENTARY INFORMATION section) are incorrect may submit either
electronic or written comments and ask for a redetermination by April
16, 2018. Furthermore, any interested person may petition FDA for a
determination regarding whether the applicant for extension acted with
due diligence during the regulatory review period by August 13, 2018.
See ``Petitions'' in the SUPPLEMENTARY INFORMATION section for more
information.

ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must be submitted on or before April 16, 2018. The https://www.regulations.gov electronic filing system will accept comments until
midnight Eastern Time at the end of April 16, 2018. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are postmarked or the delivery service
acceptance receipt is on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket Nos.
FDA-2015-E-2666; FDA-2015-E-2758; and FDA-2015-E-2664 for
``Determination of Regulatory Review Period for Purposes of Patent
Extension; FARYDAK.'' Received comments, those filed in a timely manner
(see ADDRESSES), will be placed in the dockets and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with Sec.  10.20 (21 CFR 10.20) and
other applicable disclosure law. For more information about FDA's
posting of comments to public dockets, see 80 FR 56469, September 18,
2015, or access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Beverly Friedman, Office of Regulatory
Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg.
51, Rm. 6250, Silver Spring, MD 20993,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    The Drug Price Competition and Patent Term Restoration Act of 1984
(Pub. L. 98-417) and the Generic Animal Drug and Patent Term
Restoration Act (Pub. L. 100-670) generally provide that a patent may
be extended for a period of up to 5 years so long as the patented item
(human drug product, animal drug product, medical device, food
additive, or color additive) was subject to regulatory review by FDA
before the item was marketed. Under these acts, a product's regulatory
review period forms the basis for determining the amount of extension
an applicant may receive.
    A regulatory review period consists of two periods of time: A
testing phase and an approval phase. For human drug products, the
testing phase begins when the exemption to permit the clinical
investigations of the drug becomes effective and runs until the
approval phase begins. The approval phase starts with the initial
submission of an application to market the human drug product and
continues until FDA grants permission to market the drug product.
Although only a portion of a regulatory review period may count toward
the actual amount of extension that the Director of USPTO may award
(for example, half the testing phase must be subtracted as well as any
time that may have occurred before the patent was issued), FDA's
determination of the length of a regulatory review period for a human
drug product will include all of the testing phase and approval phase
as specified in 35 U.S.C. 156(g)(1)(B).
    FDA has approved for marketing the human drug product FARYDAK
(panobinostat). FARYDAK, in combination with bortezomib and
dexamethasone, is indicated for the treatment of patients with multiple
myeloma who have received at least 2 prior regimens, including
bortezomib and an immunomodulatory agent. This indication is approved
under accelerated approval based on progression free survival.
Continued approval for this indication may be contingent upon
verification and description of clinical benefit in confirmatory
trials. Subsequent to this approval, the USPTO received patent term
restoration applications for FARYDAK (U.S. Patent Nos. 6,552,065;
6,833,384; and 7,067,551) from Novartis AG, and the USPTO requested
FDA's assistance in determining the patents' eligibility for patent
term restoration. In a letter dated October 15, 2015, FDA advised the
USPTO that this human drug product had undergone a regulatory review
period and that the approval of FARYDAK represented the first permitted
commercial marketing or use of the product. Thereafter, the USPTO
requested that FDA determine the product's regulatory review period.

II. Determination of Regulatory Review Period

    FDA has determined that the applicable regulatory review period for
FARYDAK is 4,334 days. Of this time, 3,997 days occurred during the
testing phase of the regulatory review period, while 337 days occurred
during the approval phase. These periods of time were derived from the
following dates:
    1. The date an exemption under section 505(i) of the Federal Food,
Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 355(i)) became
effective: April 15, 2003. The applicant claims April 15, 2002, as the
date the investigational new drug application (IND) became effective.
However, FDA records indicate that the IND effective date was April 15,
2003, which was the first date after receipt of the IND that the
investigational studies were allowed to proceed.
    2. The date the application was initially submitted with respect to
the human drug product under section 505(b) of the FD&C Act: March 24,
2014. FDA has verified the applicant's claim that the new drug
application (NDA) for FARYDAK (NDA 205353) was initially submitted on
March 24, 2014.
    3. The date the application was approved: February 23, 2015. FDA
has verified the applicant's claim that NDA 205353 was approved on
February 23, 2015.
    This determination of the regulatory review period establishes the
maximum potential length of a patent extension. However, the USPTO
applies several statutory limitations in its calculations of the actual
period for patent extension. In its applications for patent extension,
this applicant seeks 1,751 days or 5 years of patent term extension.

III. Petitions

    Anyone with knowledge that any of the dates as published are
incorrect may submit either electronic or written comments and, under
21 CFR 60.24, ask for a redetermination (see DATES). Furthermore, as
specified in Sec.  60.30 (21 CFR 60.30), any interested person may
petition FDA for a determination regarding whether the applicant for
extension acted with due diligence during the regulatory review period.
To meet its burden, the petition must comply with all the requirements
of Sec.  60.30, including but not limited to: Must be timely (see
DATES), must be filed in accordance with Sec.  10.20, must contain
sufficient facts to merit an FDA investigation, and must certify that a
true and complete copy of the petition has been served upon the patent
applicant. (See H. Rept. 857, part 1, 98th Cong., 2d sess., pp. 41-42,
1984.) Petitions should be in the format specified in 21 CFR 10.30.
    Submit petitions electronically to https://www.regulations.gov at
Docket No. FDA-2013-S-0610. Submit written petitions (two copies are
required) to the Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

    Dated: February 6, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-02868 Filed 2-12-18; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register: December 6, 2006 (Volume 71, Number 234)]
[Proposed Rules]
[Page 70702-70703]
[DOCID:fr06de06-18]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 70

[FDMS Docket No. EPA-R03-OAR-2006-0933; FRL-8252-4]

State Operating Permit Programs; Delaware; Amendments to the
Definition of ``a major source''

AGENCY: Environmental Protection Agency (EPA).

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: EPA proposes to approve an amendment to the State of
Delaware's operating permit program to correct the definition of ``a
major source.'' This amendment would change the definition of ``a major
source'' by removing the phrase ``but only with respect to those air
pollutants that have been regulated for that category'' from the
Regulation No. 30 (Title V) definition of a major source, as it applies
to these Federal standards. This would require all fugitive emissions
to be included in major source determination for sources subject to
Federal New Source Performance Standards (NSPS) or the National
Emissions Standards for Hazardous Air Pollutants standards (NESHAPs),
not just the pollutants regulated by the particular NSPS or NESHAP.
This amendment is necessary to make the current definition as stringent
as the corresponding provision of the Title V regulations, which went
into effect on November 27, 2001. This change will make this aspect of
Regulation No. 30 consistent with Federal rule. In the Final Rules
section of this Federal Register, EPA is approving the State's
amendment to its operating permit program as a direct final rule
without prior proposal because the Agency views this as a
noncontroversial submittal and anticipates no adverse comments. A
detailed rationale for the approval is set forth in the direct final
rule. If no adverse comments are received in response to this action,
no further activity is contemplated. If EPA receives adverse comments,
the direct final rule will be withdrawn and all public comments
received will be addressed in a subsequent final rule based on this
proposed rule. The EPA will not institute a second comment period. Any
parties interested in commenting on this action should do so at this
time.

DATES: Comments must be received in writing by January 5, 2007.

ADDRESSES: Submit your comments, identified by Docket ID Number EPA-
R03-OAR-2006-0933 by one of the following methods:
    A. http://www.regulations.gov. Follow the on-line instructions for

submitting comments.
    B. E-mail<EMAIL_ADDRESS>    C. Mail: EPA-R03-OAR-2006-0933, David Campbell, Chief, Permits and
Technical Assessment Branch, Mailcode 3AP11, U.S. Environmental
Protection Agency, Region III, 1650 Arch Street, Philadelphia,
Pennsylvania 19103.
    D. Hand Delivery: At the previously-listed EPA Region III address.
Such

deliveries are only accepted during the Docket's normal hours of
operation, and special arrangements should be made for deliveries of
boxed information.
    Instructions: Direct your comments to Docket ID No. EPA-R03-OAR-
2006-0933. EPA's policy is that all comments received will be included
in the public docket without change, and may be made available online
at http://www.regulations.gov, including any personal information

provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through http://www.regulations.gov

or e-mail. The http://www.regulations.gov Web site is an ``anonymous access''

system, which means EPA will not know your identity or contact
information unless you provide it in the body of your comment. If you
send an e-mail comment directly to EPA without going through
http://www.regulations.gov, your e-mail address will be automatically captured

and included as part of the comment that is placed in the public docket
and made available on the Internet. If you submit an electronic
comment, EPA recommends that you include your name and other contact
information in the body of your comment and with any disk or CD-ROM you
submit. If EPA cannot read your comment due to technical difficulties
and cannot contact you for clarification, EPA may not be able to
consider your comment. Electronic files should avoid the use of special
characters, any form of encryption, and be free of any defects or
viruses.
    Docket: All documents in the electronic docket are listed in the
http://www.regulations.gov index. Although listed in the index, some

information is not publicly available, i.e., CBI or other information
whose disclosure is restricted by statute. Certain other material, such
as copyrighted material, is not placed on the Internet and will be
publicly available only in hard copy form. Publicly available docket
materials are available either electronically in http://www.regulations.gov
 or in hard copy during normal business hours at the

Air Protection Division, U.S. Environmental Protection Agency, Region
III, 1650 Arch Street, Philadelphia, Pennsylvania 19103. Copies of the
State submittal are available at the Delaware Department of Natural
Resources & Environmental Control, 89 Kings Highway, P.O. Box 1401,
Dover, Delaware 19903.

FOR FURTHER INFORMATION CONTACT: Rosemarie Nino,<PHONE_NUMBER>, or by
e-mail at<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: For further information, please see the
information provided in the direct final action, with the same title,
that is located in the ``Rules and Regulations'' section of this
Federal Register publication. This action approves an amendment to the
Delaware Title V operating permit program to correct the definition of
a ``major source.''

    Dated: November 21, 2006.
William T. Wisniewski,
Acting Regional Administrator, Region III.
 [FR Doc. E6-20642 Filed 12-5-06; 8:45 am]

BILLING CODE 6560-50-P